Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Prescott

Showing results (201-210 of 299) with videos related to

Pageof 30
Sort By:
European Heart Journal. Cardiovascular Imaging|January 24, 2023
Left atrial late gadolinium enhancement in patients with ischaemic strokeBjørn Strøier Larsen, Litten Bertelsen, Hanne Christensen, et al.
European Journal of Preventive Cardiology|July 5, 2011
No gender differences in prognosis and preventive treatment in patients with AMI without significant stenosesKim Wadt Hansen, Anders Hvelplund, Steen Zabell Abildstrøm, et al.
Epidemiology (Cambridge, Mass.)|February 20, 2015
Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor statusUlla Arthur Hvidtfeldt, Anne Tjønneland, Niels Keiding, et al.
JACC. Advances|October 1, 2024
Ongoing Opioid Treatment and Symptoms of Myocardial Infarction in Calls to the Emergency Medical ServicesAnne Storgaard Nørskov, Amalie Lykkemark Møller, Christian Torp-Pedersen, et al.
The Journal of Invasive Cardiology|January 3, 2012
Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 menAnders Hvelplund, Søren Galatius, Mette Madsen, et al.
Contemporary Clinical Trials Communications|September 3, 2020
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarctionEva Prescott, John Pernow, Antti Saraste, et al.
European Heart Journal|December 19, 2018
Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable anginaJacob Reeh, Christina Bachmann Therming, Merete Heitmann, et al.
Environmental Health Perspectives|May 23, 2020
Long-Term Exposure to Air Pollution and Incidence of Myocardial Infarction: A Danish Nurse Cohort StudyJohannah Cramer, Jeanette T Jørgensen, Barbara Hoffmann, et al.
Blood Pressure|July 17, 2024
Cardiovascular events according to blood pressure thresholds recommended by ACC/AHAGowsini Joseph, Vi Thanh Pham, Per Kragh Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
Pageof 30

Showing results (201-210 of 299) with videos related to

Sort By:
Pageof 30
European Heart Journal. Cardiovascular Imaging|January 24, 2023
Left atrial late gadolinium enhancement in patients with ischaemic strokeBjørn Strøier Larsen, Litten Bertelsen, Hanne Christensen, et al.
European Journal of Preventive Cardiology|July 5, 2011
No gender differences in prognosis and preventive treatment in patients with AMI without significant stenosesKim Wadt Hansen, Anders Hvelplund, Steen Zabell Abildstrøm, et al.
Epidemiology (Cambridge, Mass.)|February 20, 2015
Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor statusUlla Arthur Hvidtfeldt, Anne Tjønneland, Niels Keiding, et al.
JACC. Advances|October 1, 2024
Ongoing Opioid Treatment and Symptoms of Myocardial Infarction in Calls to the Emergency Medical ServicesAnne Storgaard Nørskov, Amalie Lykkemark Møller, Christian Torp-Pedersen, et al.
The Journal of Invasive Cardiology|January 3, 2012
Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 menAnders Hvelplund, Søren Galatius, Mette Madsen, et al.
Contemporary Clinical Trials Communications|September 3, 2020
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarctionEva Prescott, John Pernow, Antti Saraste, et al.
European Heart Journal|December 19, 2018
Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable anginaJacob Reeh, Christina Bachmann Therming, Merete Heitmann, et al.
Environmental Health Perspectives|May 23, 2020
Long-Term Exposure to Air Pollution and Incidence of Myocardial Infarction: A Danish Nurse Cohort StudyJohannah Cramer, Jeanette T Jørgensen, Barbara Hoffmann, et al.
Blood Pressure|July 17, 2024
Cardiovascular events according to blood pressure thresholds recommended by ACC/AHAGowsini Joseph, Vi Thanh Pham, Per Kragh Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
Pageof 30